MultiHance MRI Dye Lawsuit Filed Over Gadolinium Deposition Disease Diagnosis
A Multihance lawsuit claims the MRI contrast dye gave a Louisiana man a condition known as Gadolinium Deposition Disease.
A Multihance lawsuit claims the MRI contrast dye gave a Louisiana man a condition known as Gadolinium Deposition Disease.
A MultiHance lawsuit claims the gadolinium-based contrast dye cause severe complications, permanent injuries, and the need for hospitalization.
A new report indicates that the use of gadolinium contrast agents may be unnecessary in some MRI scans.
A gadolinium exposure lawsuit blames Optimark and Multihance side effects for fibrosis of organs, skin and bones.
A gadolinium exposure lawsuit claims that IV injections of various MRI contrast dyes caused severe injury due to an allergic reaction.
Changes in children's brains may make them more susceptible to gadolinium retention after the age of two, according to the findings of a new study.
A gadolinium retention lawsuit says Multihance, Magnevist and Omniscan MRI contrast dyes are defective, resulting in injury from toxic chemicals.
Researchers say a new technique involving artificial intelligence could significantly reduce the need for gadolinium enhancement of MRI scans.
A new method for detecting gadolinium retention may also explain why the toxic chemical is being retained in the body.
Gadolinium MRI contrast dyes were linked to high rates of acute kidney injury, dialysis and increased risks of death in patients with chronic kidney disease, according to a Mayo Clinic…